Russian PCR equipment maker DNA Technology plans first overseas factory in Uttar Pradesh
The company is looking for a site of about 10,000 square metres and has opened talks with Invest UP, according to a company executive. Greater Noida: DNA Technology, a Russian…
DTAB recommends licence exemptions for home-use medical devices and first-aid kits: Report
Imported first-aid kits meant only for workplace use in sectors such as automobiles and hospitality could skip import licensing if they carry at least 60% residual shelf life. New Delhi:…
Molbio Diagnostics shares rise 9% after Jefferies starts coverage with buy rating: report
The brokerage set a target price of Rs 1,600, implying an upside of about 27 per cent over the stock’s previous close of Rs 1,255.60. New Delhi: Shares of Molbio…
Sun Pharma plans Rs 10,000 crore rupee bond sale to refinance Organon bridge loan: sources
The drugmaker is expected to issue bonds with maturities of two, three and four years to replace part of a bridge loan of nearly $12 billion. Mumbai: Sun Pharmaceutical Industries…
IHH to raise Fortis Healthcare stake to 51% over three to five years: exchange filing
The Malaysian hospital group also said it would fully cooperate with a forensic audit that the Supreme Court allowed to proceed last week. New Delhi: IHH Healthcare plans to lift…
Mukh Mantri Sehat Bima Yojana to cover 65 lakh families in Punjab: Kuldeep Dhaliwal
More than 24,000 families in the Ajnala constituency have already been issued health insurance cards under the scheme, the MLA said. Amritsar: Punjab’s Mukh Mantri Sehat Bima Yojana will extend…
PFRDA to launch NPS Swasthya with super top-up health insurance cover this week
The product allows reimbursement of medical costs without hospitalisation, a departure from insurance norms that generally tie a valid claim to a hospital stay. New Delhi: The Pension Fund Regulatory…
Insurers must compete on price and product quality, not distributor payouts: Irdai chief
Stakeholders can send comments on the distribution consultation paper until 25 October, after which draft regulations will go out for public consultation, Ajay Seth said. Mumbai: The Insurance Regulatory and…
Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets
Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…
Centre can invoke Patents Act to make costly patented cancer drugs affordable: Kerala High Court
The court stopped short of ordering the government to act, treating the matter as a policy call and asking the Centre to first gather nationwide data on how affordable such…
